News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
438,854 Results
Type
Article (32039)
Company Profile (83)
Press Release (406732)
Multimedia
Podcasts (37)
Webinars (10)
Section
Business (118882)
Career Advice (802)
Deals (18786)
Drug Delivery (71)
Drug Development (56376)
Employer Resources (69)
FDA (13216)
Job Trends (10051)
News (212400)
Policy (21796)
Tag
Academia (2198)
Accelerated approval (4)
Adcomms (14)
Allergies (77)
Alliances (31171)
ALS (67)
Alzheimer's disease (974)
Antibody-drug conjugate (ADC) (64)
Approvals (13246)
Artificial intelligence (184)
Autoimmune disease (11)
Automation (7)
Bankruptcy (160)
Best Places to Work (8050)
BIOSECURE Act (6)
Biosimilars (48)
Biotechnology (56)
Bladder cancer (66)
Brain cancer (19)
Breast cancer (220)
Cancer (1704)
Cardiovascular disease (137)
Career advice (672)
Career pathing (16)
CAR-T (97)
Cell therapy (267)
Cervical cancer (17)
Clinical research (47494)
Collaboration (529)
Compensation (137)
Complete response letters (12)
COVID-19 (1909)
CRISPR (20)
C-suite (156)
Cystic fibrosis (63)
Data (1731)
Decentralized trials (2)
Denatured (22)
Depression (32)
Diabetes (191)
Diagnostics (4194)
Digital health (14)
Diversity (9)
Diversity, equity & inclusion (20)
Drug discovery (67)
Drug pricing (80)
Drug shortages (21)
Duchenne muscular dystrophy (60)
Earnings (41179)
Editorial (27)
Employer branding (9)
Employer resources (61)
Events (61798)
Executive appointments (497)
FDA (14265)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (461)
Gene editing (53)
Generative AI (10)
Gene therapy (180)
GLP-1 (463)
Government (3529)
Grass and pollen (3)
Guidances (45)
Healthcare (14284)
Huntington's disease (11)
IgA nephropathy (19)
Immunology and inflammation (49)
Indications (20)
Infectious disease (2011)
Inflammatory bowel disease (91)
Inflation Reduction Act (7)
Influenza (35)
Intellectual property (56)
Interviews (94)
IPO (7863)
IRA (32)
Job creations (2311)
Job search strategy (623)
Kidney cancer (8)
Labor market (16)
Layoffs (225)
Leadership (4)
Legal (4135)
Liver cancer (63)
Lung cancer (254)
Lymphoma (122)
Machine learning (3)
Management (21)
Manufacturing (157)
MASH (54)
Medical device (13261)
Medtech (13265)
Mergers & acquisitions (11251)
Metabolic disorders (479)
Multiple sclerosis (62)
NASH (13)
Neurodegenerative disease (61)
Neuropsychiatric disorders (14)
Neuroscience (1360)
NextGen: Class of 2025 (4876)
Non-profit (3625)
Now hiring (17)
Obesity (240)
Opinion (85)
Ovarian cancer (65)
Pain (70)
Pancreatic cancer (63)
Parkinson's disease (98)
Partnered (12)
Patents (134)
Patient recruitment (92)
Peanut (40)
People (38324)
Pharmaceutical (23)
Pharmacy benefit managers (11)
Phase I (14075)
Phase II (20847)
Phase III (16284)
Pipeline (791)
Policy (92)
Postmarket research (1850)
Preclinical (4598)
Press Release (34)
Prostate cancer (83)
Psychedelics (19)
Radiopharmaceuticals (178)
Rare diseases (244)
Real estate (4202)
Recruiting (24)
Regulatory (15770)
Reports (19)
Research institute (2025)
Resumes & cover letters (113)
Rett syndrome (2)
RNA editing (2)
RSV (31)
Schizophrenia (57)
Series A (73)
Series B (52)
Service/supplier (5)
Sickle cell disease (42)
Special edition (3)
Spinal muscular atrophy (111)
Sponsored (17)
Startups (2434)
Stomach cancer (10)
Supply chain (48)
Tariffs (17)
The Weekly (14)
Vaccines (506)
Venture capitalists (16)
Weight loss (157)
Women's health (22)
Worklife (6)
Date
Today (104)
Last 7 days (532)
Last 30 days (1672)
Last 365 days (21138)
2025 (6730)
2024 (22537)
2023 (25882)
2022 (34679)
2021 (37285)
2020 (36637)
2019 (33129)
2018 (25388)
2017 (21403)
2016 (20915)
2015 (24350)
2014 (18354)
2013 (15274)
2012 (16657)
2011 (16893)
2010 (15099)
Location
Africa (429)
Alabama (22)
Alaska (4)
Arizona (139)
Arkansas (11)
Asia (27602)
Australia (4205)
California (3520)
Canada (1309)
China (407)
Colorado (187)
Connecticut (185)
Delaware (124)
Europe (54097)
Florida (618)
Georgia (153)
Idaho (39)
Illinois (407)
India (17)
Indiana (247)
Iowa (4)
Japan (127)
Kansas (76)
Kentucky (20)
Louisiana (9)
Maine (28)
Maryland (673)
Massachusetts (2498)
Michigan (131)
Minnesota (293)
Mississippi (2)
Missouri (52)
Montana (28)
Nebraska (19)
Nevada (37)
New Hampshire (65)
New Jersey (1233)
New Mexico (14)
New York (1163)
North Carolina (624)
North Dakota (4)
Northern California (1511)
Ohio (156)
Oklahoma (8)
Oregon (27)
Pennsylvania (934)
Puerto Rico (10)
Rhode Island (26)
South America (634)
South Carolina (21)
Southern California (1347)
Tennessee (90)
Texas (611)
United States (14628)
Utah (125)
Virginia (98)
Washington D.C. (47)
Washington State (275)
West Virginia (3)
Wisconsin (44)
438,854 Results for "tufts medical center".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
60 Degrees Pharmaceuticals, Inc. announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients.
May 30, 2024
·
11 min read
Press Releases
Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention
December 23, 2024
·
11 min read
Press Releases
Tufts Medical Center Becomes First Hospital in Massachusetts to Adopt MOLLI Surgical’s Breast Cancer Technology
July 18, 2024
·
2 min read
Press Releases
GT Medical Technologies Announces Launch of GammaTile® Center of Excellence Program and First Designation, USC Brain Tumor Center
April 9, 2025
·
3 min read
Press Releases
Leading Cardiologist & Echocardiographer Appointed Medical Director of NYU Langone’s Aortic Center
April 10, 2025
·
4 min read
Press Releases
Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board
September 20, 2024
·
5 min read
Press Releases
University Hospitals Cleveland Medical Center Activates AI for Early Lung Cancer Identification
April 2, 2025
·
4 min read
Press Releases
Pixee Medical Receives FDA 510(k) Clearance for Augmented Reality solution tailored to U.S. Ambulatory Surgery Centers
April 22, 2025
·
3 min read
Press Releases
Cagent Vascular Initiates Patient Enrollment in the Serranator® vs. POBA OCT Study at Columbia University Medical Center
April 10, 2025
·
2 min read
Business
OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (“NCP”) Following Announcement of Clinical Trial Agreement with Tufts Medical Center
OKYO Pharma Limited is pleased to announce a new agreement with Tufts Medical Center to conduct a 40-patient open-label clinical trial evaluating the efficacy and safety of OK-101 in patients with neuropathic corneal pain (“NCP”).
July 28, 2023
·
6 min read
1 of 43,886
Next
